GlaxoSmithKline PharmaceuticalsGLAXO 
$26.79-2.16%24h
-2.16%24h
Global rank2911
Market cap$4.54B
Change 7d0.90%
YTD Performance19.42%
SP500 benchmarkOutperform
P/E0
P/S0
Revenue$0
Earnings$0
Dividend yield-
Main Sector
Healthcare
Category
Market capitalization of GlaxoSmithKline Pharmaceuticals (GLAXO)
As of December 2024, GlaxoSmithKline Pharmaceuticals has a market cap of $4.54B. This makes GlaxoSmithKline Pharmaceuticals the world's 2911th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Market cap history of GlaxoSmithKline Pharmaceuticals from 2002 to 2024
-
Value:-
Market cap history of GlaxoSmithKline Pharmaceuticals from 2002 to 2024
| Year | Market Cap | Change |
|---|---|---|
| 2024 | $4.39B | 15.89% |
| 2023 | $3.79B | 43.94% |
| 2022 | $2.63B | -24.93% |
| 2021 | $3.50B | 8.17% |
| 2020 | $3.24B | 0.85% |
| 2019 | $3.21B | 6.27% |
| 2018 | $3.02B | 21.75% |
| 2017 | $2.48B | -8.81% |
| 2016 | $2.72B | -17.63% |
| 2015 | $3.30B | 3.61% |
| 2014 | $3.19B | 6.68% |
| 2013 | $2.99B | 38.29% |
| 2012 | $2.16B | 11.46% |
| 2011 | $1.94B | -16.79% |
| 2010 | $2.33B | 45.01% |
| 2009 | $1.61B | 40.09% |
| 2008 | $1.15B | 12.02% |
| 2007 | $1.02B | -11.67% |
| 2006 | $1.16B | 3.67% |
| 2005 | $1.12B | 45.67% |
| 2004 | $767.84M | 34.30% |
| 2003 | $571.75M | 87.85% |
| 2002 | $304.37M | - |
GLAXO Market Cap Today is $4.54B -2.16% - 21 Dec 2024
View largest stocks by market cap 
